MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59 | -69.3% | 46,640 | +0.1% | 0.00% | -50.0% |
| Q1 2023 | $192 | -33.1% | 46,605 | -4.8% | 0.00% | -33.3% |
| Q4 2022 | $287 | -99.9% | 48,931 | +23.6% | 0.00% | 0.0% |
| Q3 2022 | $268,000 | +21.8% | 39,597 | -16.7% | 0.00% | +50.0% |
| Q2 2022 | $220,000 | +117.8% | 47,555 | +192.4% | 0.00% | +100.0% |
| Q4 2021 | $101,000 | -70.8% | 16,263 | -55.7% | 0.00% | -50.0% |
| Q3 2021 | $346,000 | +71.3% | 36,713 | +193.8% | 0.00% | +100.0% |
| Q1 2021 | $202,000 | +12.2% | 12,496 | +84.3% | 0.00% | 0.0% |
| Q4 2020 | $180,000 | -72.5% | 6,781 | -80.7% | 0.00% | -75.0% |
| Q3 2020 | $654,000 | +64.7% | 35,108 | +107.1% | 0.00% | +33.3% |
| Q2 2020 | $397,000 | +429.3% | 16,953 | +31.4% | 0.00% | +200.0% |
| Q1 2020 | $75,000 | – | 12,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |